Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)

Market Cap	725.42M
Revenue (ttm)	2.36B
Net Income (ttm)	101.32M
Shares Out	863.60M
EPS (ttm)	0.12
PE Ratio	7.18
Forward PE	n/a
Dividend	0.05 (5.95%)
Ex-Dividend Date	May 23, 2025

Volume	133,000
Average Volume	351,450
Open	0.8200
Previous Close	0.8400
Day's Range	0.8200 - 0.8500
52-Week Range	0.7700 - 1.2800
Beta	0.64
RSI	44.58
Earnings Date	May 23, 2025

About HKG:3737

Zhongzhi Pharmaceutical Holdings Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China. The company operates through Pharmaceutical Manufacturing and Operation of Chain Pharmacies segments. It also provides Chinese patent medicines and decoction pieces under the Zeus, Liumian, and Caojinghua brand names. In addition, the company manufactures and sells food and Chinese herbs; offers detection and testing services; and manages properties. Fu...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 2,577
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 3737

Financial Performance

In 2024, HKG:3737's revenue was 2.21 billion, an increase of 8.05% compared to the previous year's 2.05 billion. Earnings were 95.21 million, a decrease of -41.51%.

Financial numbers in CNY